(Q49973375)

23 February 2018

title

Roles of neutrophils in cancer growth and progression. (English)

1 reference

23 February 2018

4

Alberto Mantovani

1 reference

23 February 2018

2

Gilda Varricchi

1 reference

23 February 2018

author name string

Maria Rosaria Galdiero

series ordinal

1

1 reference

23 February 2018

Stefania Loffredo

series ordinal

3

1 reference

23 February 2018

Gianni Marone

series ordinal

5

1 reference

23 February 2018

publication date

15 December 2017

1 reference

23 February 2018

Journal of Leukocyte Biology

published in

1 reference

23 February 2018

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Phagocytes as Corrupted Policemen in Cancer-Related Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Tumor associated macrophages and neutrophils in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Distinct Functions of Neutrophil in Cancer and Its Regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

The yin-yang of tumor-associated neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Neutrophils responsive to endogenous IFN-beta regulate tumor angiogenesis and growth in a mouse tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

CXC chemokines in cancer angiogenesis and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Chemokines and chemokine receptors: new insights into cancer-related inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Neutrophils in the activation and regulation of innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Peripheral blood neutrophil granulocytes from patients with head and neck squamous cell carcinoma functionally differ from their counterparts in healthy donors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

CXCL17 expression by tumor cells recruits CD11b+Gr1 high F4/80- cells and promotes tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Origins of tumor-associated macrophages and neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Genotoxic effects of neutrophils and hypochlorous acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma and pancreatic tumor cell lines: the role of neutrophils and neutrophil-derived elastase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Breast cancer cell uptake of the inflammatory mediator neutrophil elastase triggers an anticancer adaptive immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Neutrophils enhance invasion activity of human cholangiocellular carcinoma and hepatocellular carcinoma cells: an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

On the production of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2L) by human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Mismatch repair deficient colorectal cancer in the era of personalized treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Treatment with IFNalpha in vivo up-regulates serum-soluble TNF-related apoptosis inducing ligand (sTRAIL) levels and TRAIL mRNA expressions in neutrophils in chronic myelogenous leukemia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Neutrophils Oppose Uterine Epithelial Carcinogenesis via Debridement of Hypoxic Tumor Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

A novel p38-MAPK signaling axis modulates neutrophil biology in head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Inflammation induced by MMP-9 enhances tumor regression of experimental breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Bv8 regulates myeloid-cell-dependent tumour angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Angiogenic activity of bFGF and VEGF suppressed by proteolytic cleavage by neutrophil elastase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Group V Secreted Phospholipase A2 Induces the Release of Proangiogenic and Antiangiogenic Factors by Human Neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Transiently entrapped circulating tumor cells interact with neutrophils to facilitate lung metastasis development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Tumor entrained neutrophils inhibit seeding in the premetastatic lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Interleukin-17A Promotes Lung Tumor Progression through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Characterization of a novel population of low-density granulocytes associated with disease severity in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

The diversity of circulating neutrophils in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Myeloid-derived suppressor cell heterogeneity and subset definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Myeloid-derived suppressor cells as regulators of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Transcriptomic analysis comparing tumor-associated neutrophils with granulocytic myeloid-derived suppressor cells and normal neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Immunomonitoring and prognostic relevance of neutrophils in clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients' adverse prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

The significance of tumor-associated neutrophil density in uterine cervical cancer treated with definitive radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Neutrophil infiltration into human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Tumor-infiltrating neutrophils in pancreatic neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

The prognostic landscape of genes and infiltrating immune cells across human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Neutrophils dominate the immune cell composition in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Occurrence and significance of tumor-associated neutrophils in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

High myeloperoxidase positive cell infiltration in colorectal cancer is an independent favorable prognostic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Elevated preoperative neutrophil-to-lymphocytes ratio predicts poor prognosis after esophagectomy in T1 esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Role of neutrophil-to-lymphocyte ratio in prediction of Gleason score upgrading and disease upstaging in low-risk prostate cancer patients eligible for active surveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Performance status and neutrophil-lymphocyte ratio are important prognostic factors in elderly patients with unresectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Immune mediators as potential diagnostic tools for colorectal cancer: from experimental rationale to early clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

The secret ally: immunostimulation by anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

The future of immune checkpoint therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Up-regulation of programmed cell death 1 ligand 1 on neutrophils may be involved in sepsis-induced immunosuppression: an animal study and a prospective case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Programmed death ligand 1 on Burkholderia pseudomallei-infected human polymorphonuclear neutrophils impairs T cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Programmed death ligand 1 is over-expressed by neutrophils in the blood of patients with active tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

PD-L1-expressing neutrophils as a novel indicator to assess disease activity and severity of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJLB.3MR0717-292R

21 January 2018

Identifiers

DOI

10.1002/JLB.3MR0717-292R

1 reference

23 February 2018

1 reference

23 February 2018